Has Dena Barsoum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $508 in general payments to Dena Barsoum, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dena Barsoum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dena Barsoum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dena Barsoum, MD

Sports Medicine · White Plains, NYNPI 1669714028

Payments from drug & device makers

$508in general payments, 2019–2025

Across 6 payments — averaging $84.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stratus Medical, LLC$342
Boston Scientific$129
Ferring Pharmaceuticals Inc.$25
Fidia Pharma USA Inc.$13

What the payments were for

Food & beverage$508100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stratus Medical, LLC	2	$342
Boston Scientific	2	$129
Ferring Pharmaceuticals Inc.	1	$25
Fidia Pharma USA Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Nimbus$342
GENERAL PAIN MANAGEMENT$105

How this compares

$508 in reported general payments places this provider in the 40th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York →

Medicare billing

Part B allowed, 2024

$319,300

Medicare patients

572

Services billed

3,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	42	$1,651
Gabapentin	117	$1,241
Diclofenac Sodium	29	$305
Duloxetine Hcl	25	$302
Meloxicam	83	$185
Cyclobenzaprine Hcl	28	$171
Methylprednisolone	20	$152
Amitriptyline Hcl	15	$81
Diazepam	15	$37

Paid to pharmacies, not to this prescriber.

Other sports medicine in White Plains

Steven LeeNyc$3.3M
Riley WilliamsNew York$3.1M
Gregory DifeliceNew York$3.1M
James PaciWoodbury$2.2M
Ilya VoloshinRochester$965K
Theodore BlaineNew York$845K
Robert MeislinNew York$720K
Stephen NicholasNyc$637K
Danyal NawabiNew York$609K
Tally LassiterOneonta$460K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →